Fermenta FY25 Revenues INR 481.3 cr, up 39% YoY; Net Profit INR 76.4 cr vs year-ago loss
May 29, 2025
Mumbai (Maharashtra) [India], May 29: Fermenta Biotech Limited, India's leading manufacturer of premium-grade APIs, intermediates, and mixes of vitamins and minerals for the global markets, today announced that its consolidated revenue (other than from real estate) for the financial year ended 31 March 2025 was INR 427.0 crore, up 57% from the same year-ago period; EBITDA for FY25 was INR 83.3 crore against loss of INR 22.3 crore a year ago.